RRML - Molecular markers in cervical screening – a promise for the future

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2020): 75%

Română English

Clarivate analytics (ISI) Impact factor

Advanced search

Top 10 downloaded articles
- May 2021 -
Prognostic value of serum lact... 15
Romanian Review of Laboratory ... 8
Pseudohyponatremia and falsely... 8
Vaginal candidiasis in Konya a... 7
The possibility of clinical us... 7
Evaluation of Plasma AA/DHA+EP... 6
Prevalence of ∆F508 cystic f... 6
Predictors associated with inc... 6
Reliability of Friedewald form... 5
Frequency, Distribution and Ge... 5

Log in

Concept, Design & Programming
Dr. Adrian Man

Nr. 21(2)/2013 DOI:10.2478/rrlm-2013-0002

Molecular markers in cervical screening – a promise for the future

Mihaela Grigore, Sergiu Teleman, Didona Ungureanu, Alina Mares


Cervical cancer is one of the leading cancers in women worldwide. The detection and diagnosis of cervical carcinoma and its precursor lesions, called cervical intraepithelial lesions (CIN), represents the main goal in order to decrease the morbidity and mortality of this disease. In the majority of cases CIN resolve spontaneously. Only a minor part of the lesions develop to high-grade lesions and eventually invasive cancer and it is important to detect those CIN with potential to progress to cervical cancer. For clinical management it is important to distinguish the cervical dysplasia with regression potential in order to avoid unnecessary treatments. Many potential biomarkers have been analyzed for the characterization of cervical cancer and pre-cancer. So far, detection of HPV has been the most promising clinical application. Several new markers have been evaluated intensively and might be used in some clinical settings, mainly p16, MCM5/CDC6 and HPV RNA, integration of HPV DNA into the host genome, chromosomal imbalances. In this article, representative examples of these markers are presented in the context of improved cervical disease detection and progression.

Keywords: cervical cancer,cervical intraepithelial neoplasia,HPV,molecular markers,p16 marker

  PDF Download full text PDF
(459 KB)
How to cite
Grigore M, Teleman S, Ungureanu D, Mares A. Molecular markers in cervical screening – a promise for the future. Rev Romana Med Lab. 2013;21(2):231-9. DOI:10.2478/rrlm-2013-0002